Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Anesthesiology Clinics
|
March 2, 2016
Perioperative Ethical Issues
Arvind Chandrakantan, Tracie Saunders
Journal of Oncology Practice
|
July 2, 2013
Establishing a minority-based community clinical oncology program: the University of Medicine and Dentistry of New Jersey, New Jersey Medical School-university Hospital Cancer Center experience
Robert Wieder, Randall Teal, Tracie Saunders, et al.
Annals of Surgical Oncology
|
December 25, 2007
Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy
Lawrence E Harrison, Margarette Bryan, Lilian Pliner, et al.
Case Reports in Anesthesiology
|
April 8, 2020
Symptomatic Intrathecal Hematoma following an Epidural Blood Patch for an Obstetric Patient with Postdural Puncture Headache: A Case Report and Synthesis of the Literature
Hailey J McInerney, Manuel Lee, Tracie Saunders, et al.
Investigational New Drugs
|
July 3, 2010
A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer
Margarette Bryan, E Dianne Pulte, Kathleen C Toomey, et al.
American Journal of Clinical Oncology
|
October 24, 2002
Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas
Robert Wieder, Anna C Pavlick, Margarette Bryan, et al.
Investigational New Drugs
|
October 31, 2003
Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies
Robert Wieder, Steven C Novick, Bruce W Hollis, et al.
Frontiers in Oncology
|
February 27, 2023
A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma
Ann W Silk, Brendan Curti, Jennifer Bryan, et al.
European Journal of Medical Research
|
July 2, 2022
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors
Ann W Silk, Biren Saraiya, Roman Groisberg, et al.
Journal of the National Cancer Institute
|
November 21, 2017
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
Anshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Anesthesiology Clinics
|
March 2, 2016
Perioperative Ethical Issues
Arvind Chandrakantan, Tracie Saunders
Journal of Oncology Practice
|
July 2, 2013
Establishing a minority-based community clinical oncology program: the University of Medicine and Dentistry of New Jersey, New Jersey Medical School-university Hospital Cancer Center experience
Robert Wieder, Randall Teal, Tracie Saunders, et al.
Annals of Surgical Oncology
|
December 25, 2007
Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy
Lawrence E Harrison, Margarette Bryan, Lilian Pliner, et al.
Case Reports in Anesthesiology
|
April 8, 2020
Symptomatic Intrathecal Hematoma following an Epidural Blood Patch for an Obstetric Patient with Postdural Puncture Headache: A Case Report and Synthesis of the Literature
Hailey J McInerney, Manuel Lee, Tracie Saunders, et al.
Investigational New Drugs
|
July 3, 2010
A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer
Margarette Bryan, E Dianne Pulte, Kathleen C Toomey, et al.
American Journal of Clinical Oncology
|
October 24, 2002
Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas
Robert Wieder, Anna C Pavlick, Margarette Bryan, et al.
Investigational New Drugs
|
October 31, 2003
Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies
Robert Wieder, Steven C Novick, Bruce W Hollis, et al.
Frontiers in Oncology
|
February 27, 2023
A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma
Ann W Silk, Brendan Curti, Jennifer Bryan, et al.
European Journal of Medical Research
|
July 2, 2022
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors
Ann W Silk, Biren Saraiya, Roman Groisberg, et al.
Journal of the National Cancer Institute
|
November 21, 2017
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
Anshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.
Page
of 2